Tag: NightOwl
Resmed launches HSAT across US
April 7, 2025HME News Staff
SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.
The test, which is cleared by the U.S. Food and Drug Administration, is designed to offer health care providers a simplified, accurate and efficient way to diagnose obstructive sleep apnea from the comfort of an individual’s home, the company says.
“Now more than ever, people want health care experiences that are easy, convenient, and accessible; however,...
ResMed buys HST company
October 4, 2021HME News Staff
SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.
The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.
"Sleep labs and home tests each have critical roles to...